A Wall Street Journal opinion piece points to hard data that contradicts dour sentiment.

Growth estimates are rising, retail sales are firm, and banks continue to describe US consumers as resilient, even amid inflation fatigue and trade uncertainty.

What’s changing is how markets interpret that resilience. Defensive consumer stocks were priced for deterioration that never fully materialized.

As confidence in the underlying economy stabilizes, sentiment toward staples is quietly improving. That sets up an environment where consistency and reliability matters, and where steady operators trading at muted expectations can start to look mispriced.

You’re getting the best trade ideas. What’s your plan after you cash in?

You don’t have to figure it out alone. Take a 30-second quiz to redeem a free first call with a financial advisor in Money Pickle’s vetted network.

Make sure your wins today fuel your future success.

Procter & Gamble $PG ( ▲ 0.53% ) has not had a smooth ride over the past year. Consumer staples have lagged, inflation has pinched volumes, and investors have questioned whether defensive stocks still deserve premium multiples.

That backdrop makes recent analyst moves notable. Wells Fargo $WFC ( ▲ 0.82% ) raised its price target on Procter & Gamble to $165 while maintaining an Overweight rating. The firm is arguing that the company’s fiscal Q2 results cleared a “low bar” and kept the door open for a stronger second half.

The quarter itself was mixed. Earnings edged past expectations, while revenue came in slightly light. But the bigger takeaway was stability. Guidance held, international performance looked solid, and analysts walked away more confident than before.

Wells Fargo’s optimism rests less on near-term upside and more on changing conditions. Consumer staples multiples are sitting near historical lows, a rare setup for a sector built on consistency rather than growth spurts.

If US data improves, even modestly, Procter & Gamble could benefit disproportionately. Analysts argue that in-line performance paired with improving rate-of-change dynamics can drive meaningful stock appreciation, especially when expectations are already muted.

Other firms appear to agree. Bank of America $BAC ( ▲ 1.27% ) nudged its target higher after the earnings release, while JPMorgan $JPM ( ▲ 1.03% ) upgraded the stock to Overweight, pointing to potential margin improvement and better organic sales trends heading into 2026.

Despite the cluster of upgrades, Procter & Gamble is not universally loved. Revenue growth remains modest, and the sector still carries scars from the post-pandemic normalization and inflation shock of recent years.

That skepticism helps explain why the stock does not trade like a momentum name. But it also creates an opportunity for investors looking to buy consumer stocks at a bargain price.

Procter & Gamble is not reinventing itself. It does not need to. If staples sentiment turns and execution stays steady, boring may prove surprisingly effective again.